New England Biolabs Inks Distribution Deals | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – New England Biolabs said after the close of the market Tuesday that it has inked two new distribution agreements with Bioke and Imperial Life Sciences.

Bioke, a Dutch firm that sells reagents for signal transduction, cell culture, and molecular biology applications, serves markets in the Netherlands, Belgium, and Luxembourg. ILS supplies reagents for genomics, proteomics, cell biology, and imaging applications in India.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.